Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200031 · ClinicalTrials.gov registry record
A Cost Analysis of Interstim Therapy
A clinical trial, sponsored by MedtronicNeuro.
- Completed
- Registry status
- 150
- Enrollment target
NCT00200031: Completed study, sponsored by MedtronicNeuro.
NCT00200031 is a clinical trial that has completed, run by MedtronicNeuro. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00200031 has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
A study to examine the impact that Interstim Therapy for Urinary Control has on health care utilization and costs within a health care system and the satisfaction with treatment expressed by patients using this therapy.
Interventions
- DEVICE Interstim therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2005-07 |
| Est. Completion | 2006-04 |
What the finished NCT00200031 record still lists
NCT00200031 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Interstim therapy is the first listed.
NCT00200031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00200031 about?
NCT00200031 is a clinical study titled "A Cost Analysis of Interstim Therapy". A study to examine the impact that Interstim Therapy for Urinary Control has on health care utilization and costs within a health care system and the satisfaction with treatment expressed by patients using this therapy.
What is the current status of trial NCT00200031?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2005-07. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00200031?
The interventions under investigation include: Interstim therapy (DEVICE).
Who is sponsoring clinical trial NCT00200031?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia